Stadler Rail AG (SRAIL)
SIX Swiss Exchange · Switzerland · prices in CHF · close of 22 Oct 2026
Key indicators
| Last close | CHF 30.90 |
|---|---|
| 52-week range | 17.25 – 31.70 |
| Return, 1 month / 3 months | +2.5% / +30.5% |
| Return, 1 year / 3 years | +58.2% / +8.0% |
| Trend | Uptrend |
| RSI (14) | 57 |
| Volatility (1 year) | 38.5% |
| Worst drawdown (1 year) | -17.9% |
| Average daily value traded | 5.47M CHF |
| Dividend yield | 1.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Stadler Rail is a Swiss manufacturer of rail vehicles based in Bussnang. It designs and builds trains, trams, light rail vehicles and locomotives for public transport operators and railway companies. Its product families include regional and intercity trains, metro and tram vehicles, and rack-and-pinion railcars for mountain routes. The company also supplies signalling and service support for its fleets, and its customers are mainly transit authorities and rail operators in Switzerland, other parts of Europe and beyond.
On this site Stadler Rail AG appears as a stock on the SIX Swiss Exchange (Switzerland), code SRAIL, with prices in Swiss francs (CHF). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Stadler Rail AG (SRAIL) trades on the SIX Swiss Exchange in Switzerland. It last closed at CHF 30.90 on 22 October 2026.
Its price-based Market X-Ray is 73 out of 100 (a strong price profile), ranking 20 of 225 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 58.2% and over the last three months it rose 30.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on SIX Swiss Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 91 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 32.0% | ||
| From 52-week high | -1.9% | ||
| Momentum | 92 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 30.5% | ||
| 6-month return | 40.0% | ||
| 12-month return, skipping the last month | 54.4% | ||
| Stability (higher is calmer) | 50 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 38.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.9% | ||
| Liquidity | 71 · Strong | Trades actively. | |
| Average daily value traded | 5.47M CHF | ||
| Zero-volume days | 0.0% | ||
| Income | 41 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.6% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.1% |
|---|---|
| 1 month | +2.5% |
| 3 months | +30.5% |
| 6 months | +40.0% |
| 1 year | +58.2% |
| 3 years | +8.0% |
| 5 years | −14.4% |
Signals
| 50-day / 200-day average | 29.07 / 23.40 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | Yes |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.76 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 May 2026 | CHF 0.5000 |
| 9 May 2025 | CHF 0.2000 |
| 24 May 2024 | CHF 0.9000 |
| 16 May 2023 | CHF 0.9000 |
| 9 May 2022 | CHF 0.9000 |
| 10 May 2021 | CHF 0.8500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on SIX Swiss Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.